Sarcopenia and excess visceral fat accumulation negatively affect early urinary function after I-125 low-dose-rate brachytherapy for localized prostate cancer.
Naoyuki OgasawaraMakoto NakiriHirofumi KuroseKosuke UedaKatsuaki ChikuiKiyoaki NishiharaMitsunori MatsuoShigetaka SuekaneYoshitaka MorimatsuKenta MurotaniKoichiro MurakiChikayuki HattoriEtsuyo OgoTatsuya IshitakeTsukasa IgawaPublished in: International journal of urology : official journal of the Japanese Urological Association (2022)
Sarcopenia and excess visceral fat accumulation negatively affect urinary function early after I-125 low-dose-rate brachytherapy for prostate cancer.